MANUFACTURERS LIFE INSURANCE COMPANY, THE - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 91 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q3 2016. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
MANUFACTURERS LIFE INSURANCE COMPANY, THE ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2018$165,000
+20.4%
46,113
+3.5%
0.00%
Q1 2018$137,000
-48.1%
44,554
+6.1%
0.00%
Q4 2017$264,000
-5.4%
41,984
+2.8%
0.00%
Q3 2017$279,000
+24.6%
40,831
+30.3%
0.00%
Q2 2017$224,000
-22.8%
31,342
-0.5%
0.00%
Q1 2017$290,000
+152.2%
31,513
+10.6%
0.00%
Q4 2016$115,000
+5.5%
28,501
+0.3%
0.00%
Q3 2016$109,000
-10.7%
28,4230.0%0.00%
Q2 2016$122,000
+9.9%
28,423
+12.6%
0.00%
Q1 2016$111,000
-54.1%
25,244
+4.9%
0.00%
Q4 2015$242,000
+37.5%
24,072
+2.1%
0.00%
Q3 2015$176,000
-83.7%
23,567
+3.4%
0.00%
-100.0%
Q2 2015$1,081,000
+73.2%
22,793
+33.8%
0.00%0.0%
Q1 2015$624,000
-4.4%
17,030
+3.6%
0.00%0.0%
Q4 2014$653,000
+115.5%
16,436
+8.2%
0.00%
Q3 2014$303,000
+46.4%
15,191
-1.1%
0.00%
Q2 2014$207,000
+61.7%
15,354
+30.8%
0.00%
Q1 2014$128,000
-2.3%
11,742
+21.1%
0.00%
Q4 2013$131,0009,6950.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q3 2016
NameSharesValueWeighting ↓
683 Capital Management, LLC 600,000$2,142,0000.14%
Tekla Capital Management LLC 859,322$3,068,0000.12%
DOW CHEMICAL CO /DE/ 65,000$232,0000.08%
Candriam S.C.A. 495,613$1,769,0000.03%
A.R.T. Advisors, LLC 174,335$622,0000.02%
Baker Brothers Advisors 935,000$3,338,0000.02%
FLAGSHIP HARBOR ADVISORS, LLC 29,400$104,0000.02%
Alambic Investment Management, L.P. 17,804$64,0000.02%
Teton Advisors, Inc. 44,000$157,0000.01%
Man Group plc 737,715$2,634,0000.01%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders